Skip to main content
SpringerLink
Log in

Chemotherapy of Superficial Bladder Carcinoma

  • Chapter
Genitourinary Cancer 1

Part of the book series: Cancer Treatment and Research ((CTAR,volume 6))

  • 39 Accesses

Abstract

Superficial bladder carcinoma (O, A, B1 [1]; TIS, Ta, T1 [2]) is probably one of the most commonly diagnosed carcinomas, leaving skin tumors aside, in the United States. About 30 000 new patients will be diagnosed annually [3]. Data obtained from September 1974 through August 1976 by National Bladder Cancer Collaborative Group A (CGA) indicated that patients with and without prior history of bladder tumors were distributed in the way as shown in Table 1 [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Marshall VF: The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms. J. Urol 68: 714, 1952.

    PubMed  CAS  Google Scholar 

  2. American Joint Committee for Cancer Staging and End-Results Reporting: Manual for Staging of Cancer 1978. Chicago, Whiting, 1978, p. 113.

    Google Scholar 

  3. American Cancer Society: Estimated new cancer cases by sex for all sites — 1980. In: Ca — A Cancer Journal for Physicians 30:30, 1980.

    Google Scholar 

  4. Cutler SJ, Heney NM, Friedell GH: Longitudinal study of patients with bladder cancer: factors associated with disease recurrence and progression. In: AUA Monographs. (Bonney WW, Prout GR Jr. eds.) Vol. 1. Baltimore: Williams & Williams, 1981, p. 35.

    Google Scholar 

  5. Deming CL: The biological behavior of transitional cell papilloma of the bladder. J Urol 63: 815, 1950.

    PubMed  CAS  Google Scholar 

  6. Nichols J A, Marshall VF: Treatment of histologically benign papilloma of the urinary bladder by local excision and fulguration. Cancer 9: 566, 1956.

    Article  PubMed  CAS  Google Scholar 

  7. Pyrah LN, Raper FP, Thomas GM: Report of a follow-up of papillary tumors of the bladder. Br J Urol 36: 14, 1964.

    Article  PubMed  CAS  Google Scholar 

  8. Lerman RJ, Hutter RVP, Whitmore WF JR: Papilloma of the urinary bladder. Cancer 25: 333, 1970.

    Article  PubMed  CAS  Google Scholar 

  9. Williams JL, Hammonds JC, Saunders N: T1 bladder tumors. Br J Urol 49: 663, 1977.

    Article  PubMed  CAS  Google Scholar 

  10. Greene LF, Hanash KA, Farrow GM: Benign papilloma or papillary carcinoma of the bladder. J Urol 110: 205, 1973.

    PubMed  CAS  Google Scholar 

  11. O’Flynn JD, Smith JM, Hanson JS: Transurethral resection for assessment and treatment of vesical neoplasms. Urology 1: 38, 1975.

    Google Scholar 

  12. Barnes RW, Dick AL, Hadley HL Johnston OL: Survival following transurethral resection of bladder carcinoma. Cancer Res 37: 2895, 1977.

    PubMed  CAS  Google Scholar 

  13. Althausen AF, Prout GR Jr, Daly JJ: Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 116: 575, 1976.

    PubMed  CAS  Google Scholar 

  14. Jones HC, Swinney J: Thio-tepa in the treatment of tumors of the bladder. Lancet 2: 615, 1961.

    Article  PubMed  CAS  Google Scholar 

  15. Esquival EL, Mackenzie AR, Whitmore WF: Treatment of bladder tumors by instillation of thiotepa and 5-fluorouracil. Invest Urol 2: 381, 1965.

    Google Scholar 

  16. Abbassian A, Wallace DM: Intracavitary chemotherapy of diffuse non-infiltrating papillary carcinoma of the bladder. J Urol 96: 461, 1966.

    PubMed  CAS  Google Scholar 

  17. Veenema RJ, Dean AL Jr., Roberts M, Fingerhut B, Chowdhury BK, Tarassoly H: Bladder carcinoma treated by direct instillation of thio-tepa. J Urol 88: 60, 1962.

    PubMed  CAS  Google Scholar 

  18. Veenema RJ, Dean AL Jr., Uson AC, Roberts M, Longo F: Thiotepa bladder instillations: therapy and prophyllaxis for superficial bladder tumors. J Urol 101: 711, 1969.

    PubMed  CAS  Google Scholar 

  19. Edsmyr F, Bowman J: Instillation of thio-tepa (Tifosyl) in vesical papillomatosis. Acta Radiol (Ther) (Stockh) 9: 395, 1970.

    CAS  Google Scholar 

  20. Pavone-Macaluso M: Chemotherapy of vesical and prostatic tumors. Br J Urol 43: 701, 1971.

    Article  PubMed  CAS  Google Scholar 

  21. Nieh PT, Daly JJ, Heaney JA, Heney NM, Prout GR Jr.: The effect of intravesical thio-tepa on normal and tumor epithelium. J Urol 119: 59, 1978.

    PubMed  CAS  Google Scholar 

  22. Koontz WW, Jr., Prout GR, Jr., Smith W, Frable WJ, Minnis JE: The use of intravesical thiotepa in the management of non-invasive carcinoma of the bladder. J. Urol. 125: 307, 1981.

    PubMed  Google Scholar 

  23. Melicow MM, Holowell J: Intra-urothelial cancer: Carcinoma-insitu, Bowen’s disease of the urinary system: Discussion of 30 cases. J Urol 68: 763, 1952.

    PubMed  CAS  Google Scholar 

  24. Eisenberg RB, Roth RB, Schweinsberg MH: Bladder tumors and associated proliferative mucosal lesions. J Urol 84: 544, 1960.

    PubMed  CAS  Google Scholar 

  25. Schade ROK, Swinney J: Pre-cancerous changes in bladder epithelium. Lancet 2: 943, 1968.

    Article  PubMed  CAS  Google Scholar 

  26. Koss LG, Tiamson EM, Robbins MA: Mapping cancerous and pre-cancerous bladder changes. A study of urothelium in ten surgically removed bladders. JAMA 227: 281, 1974.

    Article  PubMed  CAS  Google Scholar 

  27. Utz DC, Hanash KA, Farrow GM: The plight of the patient with carcinoma-in-situ of the bladder. J Urol 103: 160, 1970.

    PubMed  CAS  Google Scholar 

  28. Melamed MR, Grabstald H, Whitmore WF Jr: Carcinoma-in-situ of the bladder: Clinico- pathologic study of a case with suggested approach to detection. J Urol 96: 466, 1966.

    PubMed  CAS  Google Scholar 

  29. Moloney PJ, Elliott GR, McLaughlin M, Sincleir AB: In situ transitional cell carcinoma and the non-specifically inflamed contracting bladder. J Urol 111: 162, 1974.

    PubMed  CAS  Google Scholar 

  30. Hultengren N, Orell SR: Widespread in situ carcinoma of the bladder with multifocal early invasion: report of a case subjected to total cystectomy. Scand J Urol Nephrol 5: 273, 1971.

    Article  PubMed  CAS  Google Scholar 

  31. Yates-Bell AJ: Carcinoma-in-situ of the bladder. Br J Surg 58: 359, 1971.

    Article  PubMed  CAS  Google Scholar 

  32. Utz DC, Zincke H: The masquerade of bladder carcinoma-in-situ as interstitial cystitis. Trans Am Assoc Genitourin Surg 65: 64, 1973.

    PubMed  CAS  Google Scholar 

  33. Boyd PJR, Burnand KG: Site of bladder tumor recurrence. Lancet 3: 1290, 1974.

    Article  Google Scholar 

  34. Page BH, Levison VB, Curwen MP: The site of recurrence of non-infiltrating bladder tumors. Br J Urol 50: 237, 1978.

    Article  PubMed  CAS  Google Scholar 

  35. Heney NM, Nocks, BN, Daly JJ, Prout GR, Jr., Newall JB, Griffin PP, Perrone TL, Szyfel- bein WM: Ta and T1 bladder cancer: location, recurrence and progression. J. Urol (In press.).

    Google Scholar 

  36. Soloway MS: Intravesical and systemic chemotherapy of murine bladder cancer. Cancer Res 37: 2918, 1977.

    PubMed  CAS  Google Scholar 

  37. Sandberg AA: Chromosome markers and progression in bladder cancer. Cancer Res 37: 2950, 1977.

    PubMed  CAS  Google Scholar 

  38. Falor WH, Ward RM: Prognosis in well differentiated non-invasive carcinoma of the blad¬der based on chromosomal analysis. Surg Gynec & Obstet 144: 515, 1977.

    CAS  Google Scholar 

  39. Leenglmayer G, Czech K: Absorption studies on intraluminal thio-tepa for topical cytostatic treatment of low-stage bladder tumors. J Urol 106: 72, 1971.

    Google Scholar 

  40. Watkins WE, Kozak JA, Flanagan JJ: Severe pancytopenia associated with the use of intravesical thiotepa. J Urol 98: 470, 1967.

    PubMed  CAS  Google Scholar 

  41. Drew JE, Marshall VF: Effects of topical thiotepa on the recurrence rate of superficial bladder cancers. J Urol 68: 740, 1968.

    Google Scholar 

  42. Wescott JW: The prophylactic use of thiotepa in transitional cell carcinoma of the bladder. J Urol 96: 913, 1966.

    PubMed  CAS  Google Scholar 

  43. Byar D, Blackard C: Comparisons of placebo, pyridoxine and topical thiotepa in preventing recurrence of stage I bladder cancer. Urology 10: 556, 1977.

    Article  PubMed  CAS  Google Scholar 

  44. Burnand KG, Boyd PJR, Mayo ME, Shuttleworth KED, Lloyd-Davies RW: Single dose intravesical thiotepa as an adjuvant to cytodiathermy in the treatment of transitional cell bladder carcinoma. Br J Urol 48: 55, 1976.

    Article  PubMed  CAS  Google Scholar 

  45. Gavrell GJ, Lewis RW, Meehan WL, LeBlanc GA: Intravesical thiotepa in the immediate postoperative period in patients with recurrent transitional cell carcinoma of the bladder. J Urol 120: 410, 1978.

    PubMed  CAS  Google Scholar 

  46. Riddle PR, Wallace DM: Intracavitary chemotherapy for multiple non-invasive bladder tumors. Br J Urol 43: 181, 1971.

    Article  PubMed  CAS  Google Scholar 

  47. Riddle PR: The management of superficial bladder tumors with intravesical thiotepa. Br J Urol 45: 84, 1973.

    PubMed  CAS  Google Scholar 

  48. Riddle PR, Chisholm GD, Trott PA, Pugh RCB: Flat carcinoma in situ of the bladder. Br J Urol 47: 829, 1976.

    Article  Google Scholar 

  49. Fitzpatrick JM, Khan O, Oliver RTD, Riddle PR: Long-term follow-up in patients with superficial bladder tumors treated with intravesical Epodyl. Br J Urol 51: 545, 1980.

    Article  Google Scholar 

  50. Riddle P: Survival in patients treated with epodyl (1968-1978). In: Bladder Tumors and Other Topics in Urological Oncology. (Pavlone-Macaluso M, Smith PH, Edsmyr F, eds.) Vol. 1, p. 33, 1980.

    Google Scholar 

  51. Hannestad R, Otnes B: Epodyl in the treatment of bladder cancer. Tidsskr Nor Laegeforen 96: 25, 1976.

    PubMed  CAS  Google Scholar 

  52. Robinson MRG, Shetty MB, Richards B, Bastable J, Glashan RW, Smith PH: Intravesical Epodyl in the management of bladder tumors: combined experience of the Yorkshire Uro-logical Cancer Research Group. J Urol 118: 972, 1977.

    PubMed  CAS  Google Scholar 

  53. Nielsen HV, Thybo E: Epodyl treatment of bladder tumors. Scand J Urol Nephrol 13: 59, 1979.

    Article  PubMed  CAS  Google Scholar 

  54. Popa G, Peters HJ, Potempa J: Conservative treatment of bladder papillomas with Epodyl. Therapiewoche 28: 2013, 1978.

    Google Scholar 

  55. Smith JF, Lane V, O’Flynn JD: Epodyl in management of invasive vesical neoplasms. Urol 11: 474, 1978.

    Article  PubMed  CAS  Google Scholar 

  56. Pavone-Macaluso M: Intravesical treatment of superticial (Tl) urinary bladder tumors. A review of a 15-year experience. In: Diagnostics and Treatment of Superficial Urinary Blad¬der Tumors. Stockholm: Montedison Lakemedel, A.B., 1979, p. 21.

    Google Scholar 

  57. Niijima T: Intravesical therapy with adriamycin and new trends. In: Diagnostics and Treatment of Superficial Urinary Bladder Tumors. Stockholm: Montedison Lakemedel, A.B., 1979, p. 37.

    Google Scholar 

  58. Edsmyr F, Burlin T, Boman J, Duchek N, Esposti PL, Gustafson H, Wilkinson H: Intravesical therapy with adriamycin in patients with superficial bladder cancer. In: Diagnostics and Treatment of Superficial Urinary Bladder Tumors. Stockholm: Montedison Lakemedel, A.B., 1979, p. 45.

    Google Scholar 

  59. Jacobi SH, Kurth KH, Klipper KF, Hohenfeller R: On the biological behavior of Tl transitional cell tumors of the urinary bladder and initial results of the prophylactic use of topical adriamycin under controlled and randomized conditions. In: Diagnostics and Treatment of Superficial Urinary Bladder Tumors. Stockholm: Montedison Lakemedel, A.B., 1979, p. 83.

    Google Scholar 

  60. Banks MD, Pontes JE, Izbicki RM, Pierce JM Jr.: Topical instillation of doxorubicin hydrochloride in the treatment of recurring superficial transitional cell carcinoma of the bladder. J Urol 118: 757, 1977.

    PubMed  CAS  Google Scholar 

  61. Wakaki S, Muramo H, Tamora K, Shipmpizu G, Kato E, Kamada H, Kudo S, Fujimoto Y: Isolation of new fractions of antitumor mitomycins. Antibiot Chemother 8: 228, 1958.

    CAS  Google Scholar 

  62. Personal communication, Bristol Laboratories, 1980 (IKH).

    Google Scholar 

  63. Lown JW: The molecular mechanism of antitumor action of the mitomycins. In: Mitomycin C-Current Status and New Developments. ( Carter SK, Crooke ST, eds.) New York: Academic Press, 1979, p. 5.

    Google Scholar 

  64. Daskal Y, Crooke ST: Morphological effects of Mitomycin C on cellular fine structure. In: Mitomycin C-Current Status and New Developments. ( Carter SK, Crooke ST, eds.) New York: Academic Press, 1979, p. 41.

    Google Scholar 

  65. Mishina T, Oda K, Murata S, Ooe H, Mori Y, Takashi T: Mitomycin C bladder instillation therapy for bladder tumors. J Urol 114: 217, 1975.

    PubMed  CAS  Google Scholar 

  66. Reich SD: Clinical pharmacology of Mitomycin C. In: Mitomycin C-Current Status and New Developments. ( Carter SK, Crooke ST, eds.) New York: Academic Press, 1979, p. 243.

    Google Scholar 

  67. DeFuria MD, Bracken RB, Johnson DE, Soloway MS, Merrin CE, Morgan LR, Miller HC, Crooke ST: Phase I-II study of Mitomycin C topical therapy for low-grade, low-stage transitional cell carcinoma of the bladder: an interim report. Cancer Treat Rep 64: 225, 1980.

    PubMed  CAS  Google Scholar 

  68. Bracken RB, Johnson DE, von Eschenbach AC, Swanson DA, DeFuria D, Crooke S: Role of intravesical Mitomycin C in management of superficial bladder tumors. Urology 16: 11, 1980.

    Article  PubMed  CAS  Google Scholar 

  69. Caldwell WL: Radiotherapy: Definitive, integrated and palliative therapy. Urol Clin North Am 3: 129, 1975.

    Google Scholar 

  70. Caldwell WL, Bagshaw MA, Kaplan, HS: Efficacy of linear accelerator X-ray therapy in cancer of the bladder. J Urol 97: 294, 1967.

    PubMed  CAS  Google Scholar 

  71. Goffmet DR: Radiotherapy for invasive carcinoma. Presented at Stanford University Medical Center Second Annual Symposium on Disease of the Urinary Tract, March, 1974.

    Google Scholar 

  72. Van der Werf-Messing B: Cancer of the bladder treated with intracavitary application of Cobalt 60 beads. Clin Radiol 22: 101, 1971.

    Article  PubMed  Google Scholar 

  73. Buschke F: Supervoltage irradiation: prophylactic versus therapeutic use for transitional cell carcinoma of the bladder, Group I. JAMA 206: 2724, 1968.

    Article  PubMed  CAS  Google Scholar 

  74. Hewitt CB, Kiser WS, Antunez AR, Chernak ES: Intracavitary radiation in the treatment of bladder tumors. J Urol 107: 603, 1972.

    PubMed  CAS  Google Scholar 

  75. Van der Werf-Messing B: Carcinoma of the bladder treated by suprapubic radium implants. The value of additional external irradiation. Eur J Cancer 5: 277, 1969.

    Article  PubMed  Google Scholar 

  76. Olsson CA, Chute R, Rao N: Immunological reduction of bladder carcinoma recurrence rate. Trans Am Assoc Genitourin Surg 65: 66, 1973.

    PubMed  CAS  Google Scholar 

  77. Morales A, Ersil B: Prophylaxis of recurrent bladder cancer with bacillus Calmette-Guerin. In: Cancer of the Genitourinary Tract. ( Johnson, Samuels, eds.) New York: Raven Press, 1979, p. 121.

    Google Scholar 

  78. Morales A: Adjuvant immunotherapy in superficial bladder cancer. Nat Cancer Inst Monogr 49: 315, 1978.

    PubMed  Google Scholar 

  79. Lamm DL, Thor DE, Harris SC, Reyna JA, Stogdill VD, Radwin HM: BCG immunotherapy of superficial bladder cancer. J Urol 124: 38, 1980.

    PubMed  CAS  Google Scholar 

  80. Lamm DL: Personal communication, 1980 ( GRP, Jr.).

    Google Scholar 

  81. National Bladder Cancer Collaborative Group A: Unpublished data, 1980.

    Google Scholar 

  82. Soloway MS: The management of superficial bladder cancer. Cancer 45: 1856, 1980.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. George R. Prout Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Kathleen Hagen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Duke University Medical Center, Post Office Box 2977, Durham, NC, 27110, USA

    David F. Paulson M.D. (Associate Professor of Urology) (Associate Professor of Urology)

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Martinus Nijhoff Publishers bv, The Hague

About this chapter

Cite this chapter

Prout, G.R., Hagen, I.K. (1982). Chemotherapy of Superficial Bladder Carcinoma. In: Paulson, D.F. (eds) Genitourinary Cancer 1. Cancer Treatment and Research, vol 6. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7436-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-7436-4_6

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-7438-8

  • Online ISBN: 978-94-009-7436-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation